Subscribe to STAT+ and access exclusive benefits
When you're a STAT+ subscriber, you get to enjoy perks like free access to our new CRISPR TRACKR, discounts on our STAT Reports, as well as in-depth daily coverage and analysis of the biotech, pharma, and health tech industries and exclusive newsletters. Subscribe today to join our community.
JOIN STAT+
Here's what STAT+ subscribers can access this month
Date: Thursday, February 24, 2022
Time: 1:00 p.m. ET
Last summer, Intellia reported the first data showing that CRISPR could be used in the body to combat a disease. That early data was so eye-catching it was published in the New England Journal of Medicine. But what are the next steps? The company’s CEO John Leonard joins STAT to lay them out and answer your questions.
REGISTER
Date: Thursday, March 31, 2022
Time: 9:00 a.m. - 5:30 p.m. ET
This full-day event will give you an inside look at the technologies and procedures at the cutting edge of health and medicine. With STAT reporters leading the conversations, you’ll hear from executives, researchers, scientists, and investors and learn about the latest efforts to battle diseases and help patients. You can be a part of our Summit virtually, or apply to attend in person.
STAT+ Subscribers can unlock a 20% discount with the STAT+ Subscriber Viewer Pass.
REGISTER
STAT’s CRISPR TRACKR has been rebuilt from the ground up to make it easier to use and more informative. Curated by STAT’s CRISPR specialist, the tool allows readers to follow along with the most important developments in this fast-changing field. New features include the ability to easily search the studies we're tracking, filter by key attributes, and increased detail level about each study. Access to this tool is free for STAT+ subscribers.
LEARN MORE
The seismic breakthroughs in science and medicine — and the challenges that lie ahead for scientific institutions and health care systems — took center stage at our 2021 STAT Summit. Taken together, these stories underscore the important conversations that are taking place, as researchers, health care industry leaders, and policymakers navigate the future of science and medicine. We hope this e-book presents a useful exploration of these concepts in the year to come.
DOWNLOAD NOW
Gone are the days where a type 1 diabetes diagnosis meant a lifetime of finger pricking and injections. Today, almost half of the 4 million Americans living with type 1 diabetes use devices called continuous glucose monitors, or CGMs, to monitor their glucose levels and regulate their insulin levels in real-time. In our latest report, written by STAT’s Katie Palmer, we’ve gathered our best intelligence on the burgeoning industry of CGM, and where it’s likely to head next.
STAT+ Subscribers enjoy 20% off of this report (and future ones like it) using the code STAT+.
Learn More
STAT+ Reads
In case you missed them, here are some of our favorite STAT+ stories from this past month:
Read more
Still on the fence? Get to know our team.
We have a few free events and products that you can check out. They'll help you get to know the STAT+ team a little better before you invest in a subscription.
Date: Friday, February 1o, 2022
Time: 8:00 a.m. ET
Run by Black journalists at The Boston Globe, “Black News Hour” delivers reliable news that connects with our community and expands on deeper issues impacting our city. Tune in for this conversation on Covid-19 disparities and mental health, co-hosted by STAT's general assignment reporter and associate editorial director of events, Nicholas St. Fleur.
LEARN MORE
No comments